Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Longkun Wang"'
Publikováno v:
Autoimmunity, Vol 57, Iss 1 (2024)
Lupus nephritis (LN) is a highly prevalent complication of systemic lupus erythematosus (SLE). Long non-coding RNAs (lncRNAs) are essential modulators in multiple types of human diseases, including LN. In the current study, we searched on online GEO
Externí odkaz:
https://doaj.org/article/e0a2325bc2f64c16beaf902626ae39e7
Autor:
Lu Lu, Longkun Wang, Lin Zhao, Jing Liao, Chunqian Zhao, Xiaohan Xu, Fengshan Wang, Xinke Zhang
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 10; Pages: 8753
The high vascularization of glioma highlights the potential value of anti-angiogenic therapeutics for glioma treatment. Previously, we designed a novel vascular-targeting and blood–brain barrier (BBB)-penetrating peptide, TAT-AT7, by attaching the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a7d6b7e2d0a12e4a7424352ab7e9f15
Publikováno v:
Expert opinion on drug delivery. 19(2)
Paclitaxel is a powerful and effective anti-tumor drug with wide clinical application. However, there are still some limitations, including poor water solubility, low specificity, and susceptibility to drug resistance. The peptide-drug conjugates (PD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6d551b22e0304dc1e7c1649b3dc0ddd
https://pubmed.ncbi.nlm.nih.gov/35130795
https://pubmed.ncbi.nlm.nih.gov/35130795
Autor:
Lin Zhao, Aijun Wang, Yan-Na Cheng, Hongyuan Chen, Fengshan Wang, Lu Lu, Xinke Zhang, Longkun Wang
Publikováno v:
International Journal of Nanomedicine
Lu Lu,1 Hongyuan Chen,2 Longkun Wang,1 Lin Zhao,3 Yanna Cheng,3 Aijun Wang,4 Fengshan Wang,1 Xinke Zhang3 1Key Laboratory of Chemical Biology (Ministry of Education), Institute of Biochemical and Biotechnological Drug, School of Pharmaceutical Scienc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43ee169549e411b0d40635eda8c294a4
https://pubmed.ncbi.nlm.nih.gov/33209022
https://pubmed.ncbi.nlm.nih.gov/33209022
Publikováno v:
Pest Management Science. 74:1630-1636
BACKGROUND Actinidia chinensis Planch, which is distributed only in China, has been used to treat hepatitis and cancer. The objective of the present work was to identify the antiviral active ingredient of A. chinensis root bark (ACRB). RESULTS Bioass
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e874a74cf160ec8f3a1ac9e8aef56504
https://doi.org/10.1002/ps.4854
https://doi.org/10.1002/ps.4854
Publikováno v:
Pest management science. 74(7)
Actinidia chinensis Planch, which is distributed only in China, has been used to treat hepatitis and cancer. The objective of the present work was to identify the antiviral active ingredient of A. chinensis root bark (ACRB).Bioassay-guided isolation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::27458c3aa9550701304c138a06a0c6c4
https://pubmed.ncbi.nlm.nih.gov/29318764
https://pubmed.ncbi.nlm.nih.gov/29318764